Support Activities of the CEB in the National Cancer Insitute

CEB 在国家癌症研究所的支持活动

• 批准号: 8181900
• 负责人: SHANTU AMIN
• 金额: $ 51.48万
• 依托单位: PENNSYLVANIA STATE UNIV HERSHEY MED CTR
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-08-01 至 2011-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8181900
• 关键词: Aromatic Polycyclic Hydrocarbons; Biological; Cancer Biology; Cancer Etiology; Chemical Agents; Chemicals; Chemopreventive Agent; Contracts; Etiology; Human; Malignant Neoplasms; National Cancer Institute; Research Support; Resources; chemical carcinogen; chemical carcinogenesis; programs

"""The objective of this contract is to provide synthesis of selected chemical carcinogens, derivatives of polynuclear aromatic hydrocarbons (PAH) and chemopreventive agents in support of the Cancer Etiology Branch located within the Divison of Cancer Biology at the National Cancer Institute. The Cancer Etiology Branch (CEB) supports research programs dealing with biological, chemical, and physical agents that are known or possible etiological factors or co-factors in cancer. "

该合同的目的是提供选定的化学致癌物、多核芳烃 (PAH) 衍生物和化学预防剂的合成，以支持位于国家癌症研究所癌症生物学部门内的癌症病因学分支。癌症病因学分支 (CEB) 支持涉及已知或可能的病因因素或辅助因素的生物、化学和物理因素的研究项目。 癌症。 ”